Debridement and the diabetic foot.

  1. Lázaro Martínez JL 2
  2. ALVARO AFONSO, FRANCISCO JAVIER 2
  3. Ahluwalia R 3
  4. Baker N 4
  5. Ríos-Ruh JM 5
  6. Rivera-San Martin G 6
  7. Van Acker, K. 1
  1. 1 Centre de Santé des Fagnes. Chimay. Belgium.
  2. 2 Diabetic Foot Unit. Universidad Complutense de Madrid. Spain
  3. 3 Kings College Hospital. London. United Kingdom
  4. 4 Muzaina Vascular. Jabriya. Kuwait
  5. 5 Consorci Sanitari Integral. Barcelona. Spain
  6. 6 Diabetic Foot Unit. Hospital Universitario Donostia. Spain
Mostrar afiliaciones +
Revista:

Año de publicación: 2019

Páginas: 1-10

Tipo: Documento de Trabajo

GOOGLE SCHOLAR lock_openAcceso abierto editor

Resumen

Debridement is part of the standard of care for diabetic foot ulcers.There are several methods (sharp/surgical, biological, autolytic,biochemical and osmotic) but not a lot of evidence to supportchoosing one method over another. New foot ulcer therapies andtechnology appear regularly, but most are too expensive or difficult toimplement in most high-need areas. All of these factors make it verydifficult for healthcare professionals to choose the optimaldebridement method for their patients.The following article looks at the various debridement methods froma clinical perspective, outlining the advantages and disadvantages ofeach in the context of daily practice. Our aim is to give healthcarepractitioners some sound data to help them make best possibletreatment decisions wherever they are practicing.

Referencias bibliográficas

  • Edmonds M, Foster A. Stage 3: The ulcerated foot. Managing the Diabetic Foot. London: Blakewell Science, 2000:45–76.
  • Game FL, Apelqvist J, Attinger C, et al. Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes Metab Res Rev 2016; 32 (suppl 1): 154–68.
  • Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev. 2010(1):CD003556.
  • Tallis A, Motley TA, Wunderlich RP, et al. Clinical and economic assessment of diabetic foot ulcer debridement with collagenase: results of a randomized controlled study. Clin Ther. 2013;35(11):1805-1820.
  • Patry J, Blanchette V. Enzymatic debridement with collagenase in wounds and ulcers: a systematic review and meta-analysis. Int Wound J. 2017;14(6): 1055-1065.
  • Nishijima A, Gosho M, Yoshida R, et al. Effective wound bed preparation using maggot debridement therapy for patients with critical limb ischaemia. J Wound Care. 2017;26(8):483-489.
  • Siavash M, Shokri S, Haghighi S, Shahtalebi MA, Farajzadehgan Z. The efficacy of topical royal jelly on healing of diabetic foot ulcers: a doubleblind placebo-controlled clinical trial. Int Wound J. 2015;12(2):137-142.
  • Crone S, Garde C, Bjarnsholt T, Alhede M. A novel in vitro wound biofilm model used to evaluate low-frequency ultrasonic-assisted wound debridement. J Wound Care. 2015;24(2):64, 66-69, 72.
  • Herberger K, Franzke N, Blome C, Kirsten N, Augustin M. Efficacy, tolerability and patient benefit of ultrasound-assisted wound treatment versus surgical debridement: a randomized clinical study. Dermatology. 2011;222(3):244-24.